All articles by Phillip Broadwith – Page 24
-
Business
Portable detector shines light on fake drugs
Testing for counterfeit antimalarials in Africa will help validate a new tool for inspectors
-
Business
US sues Novartis over alleged kickbacks
Company fraudulently paid pharmacies to switch patients onto its drugs, government claims
-
Business
Ireland picks preferred drugs
Using the cheapest of equivalent options could save healthcare providers millions
-
Business
1050 jobs shed in Sabic restructuring
Cuts will be spread across European operations, but the Netherlands and UK take the brunt
-
Business
Objections raised to GSK pay-for-delay deals
The UK Office of Fair Trading believes deals to delay generic drugs infringed competition laws
-
Business
Deadly blast destroys US fertiliser plant
Up to 15 dead and over 160 injured in a fire and explosion in Waco, Texas
-
News
Biofuels are expensive and unsustainable, report says
UK think tank Chatham House criticises EU fuel policy
-
Research
Polymer lubricant may stave off knee surgery
Development of new synthesis method for high molecular weight polymer, which could be used to lubricate joints
-
Business
Waitrose bans neonicotinoid pesticides
Supermarket introduces precautionary ban on fresh produce suppliers using neonicotinoids until their effect on bees is clarified
-
Business
BASF introduces cell-based allergen test
Non-animal test for cosmetic ingredients to comply with Reach regulation
-
Business
Veolia and Total open oil recycling plant
Osilub plant will re-refine used oils into high grade engine lubricants
-
Feature
From molecules to medicines
Turning an active drug molecule into a finished product requires as much chemistry as developing the drug in the first place, as Phillip Broadwith discovers
-
Business
Morning sickness drug reintroduced to US
After being withdrawn due to litigation, the drug has been approved by the FDA
-
Business
European project to boost industry energy efficiency
Initiative will focus on smaller companies and provide tools to assess and reduce energy use
-
Business
Roche to release Tamiflu trial data
The company will drip feed data to the Cochrane Collaboration, but with some elements redacted
-
Research
A solution to fluoronium riddle
Elegant experiment lets chemists glimpse the elusive ion by tallying isomers
-
Business
Amylin headquarters to close with further job losses
Bristol-Myers Squibb plans to shutter the San Diego, US, site following last year’s merger
-
News
Regeneron expands, creating 400 new jobs
US biotech firm announces second expansion in six months
-
Research
New antimalarial drug class resists resistance
Drug candidate looks promising as scientists draw on past failures to address toxicity problems
-
Business
AstraZeneca partners with Moderna for $240 million
Pharma company sheds more jobs and backs messenger RNA therapeutics